高樹庚，1966年生，籍貫山東，胸外科專家，腫瘤醫院副院長，主任醫師，博士生導師。1984年考入山東醫科大學臨床醫學專業，1989年獲得學士學位。1995年在中國協和醫科大學腫瘤學專業攻讀碩士學位，從事胸部腫瘤相關研究。2002年在中國協和醫科大學腫瘤學專業攻讀博士學位，從事胸部腫瘤臨床和轉化研究。2011年進入北京協和醫學院腫瘤研究所進行博士后研究工作，主要從事胸部腫瘤相關研究。1995年升為主治醫師。2003年為副主任醫師，2008年為主任醫師。

肺癌微創外科治療，早期非小細胞肺癌術式的創新及改進；局部晚期非小細胞肺癌新輔助治療模式構建；探索基于外周血ctDNA改變在肺癌復發轉移預測中的應用及其相關機制，推動基礎研究的臨床轉化。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1. Guo W#, Zhou B#, Yang Z#, Liu X, Huai Q, Guo L, Xue X, Tan F, Li Y, Xue Q, Gao S*, He J. Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma. EBioMedicine. 2022 Oct;84:104281. (IF=11.205)

2. Zhou B#, Bie F#, Zang R, Zhang M, Song P, Liu L, Peng Y, Bai G, Zhao J*, Gao S*. RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer. EBioMedicine. 2022 Oct;84:104268. (IF=11.205)

3. Qiu B#, Ji Y#, Zhang F, Bai G, Xue Q, Polaczek M, Tosi D, Koike T, Gao S*, He J. Outcomes and experience of anatomical partial lobectomy. J Thorac Cardiovasc Surg. 2022 Sep;164(3):637-647.e1. (IF=6.439)

4. Guo W#, Chen X, Liu R, Liang N, Ma Q, Bao H, Xu X, Wu X, Yang S, Shao Y, Tan F, Xue Q, Gao S*, He J. Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling. EBioMedicine. 2022 Jul;81:104131. (IF=11.205)

5. Zhang F#, Guo W#, Zhou B#, Wang S, Li N, Qiu B, Lv F, Zhao L, Li J, Shao K, Xue Q, Gao S*, He J. Three-Year Follow-Up of Neoadjuvant Programmed Cell Death Protein-1 Inhibitor (Sintilimab) in NSCLC. J Thorac Oncol. 2022 Jul;17(7):909-920. (IF=20.121)

6. Zhou B#, Zang R, Zhang M, Song P, Liu L, Bie F, Peng Y, Bai G, Gao S*. Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study. EBioMedicine. 2022 Apr;78:103951. (IF=11.205)

7. Wang S#, Yuan P#, Mao B#, Li N, Ying J, Tao X, Tang W, Zhang L, Geng X, Zhang F, Xue Q, Wu L, Zhang H*, Gao S*, He J. Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade. NPJ Precis Oncol. 2022 Jan 13;6(1):2. (IF=10.092)

8. Qiu B#, Guo W#, Zhang F, Lv F, Ji Y, Peng Y, Chen X, Bao H, Xu Y, Shao Y, Tan F, Xue Q, Gao S*, He J. Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC. Nat Commun. 2021 Nov 19;12(1):6770. (IF=17.694)

9. Yang Z#, Xu J, Li L, Li R, Wang Y, Tian Y, Guo W, Wang Z, Tan F, Ying J, Jiao Y, Gao S*, Wang J*, Gao Y*, He J*. Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma. Nat Commun. 2020 Sep 28;11(1):4878. (IF=14.919)

10. Gao S#, Li N, Gao S, Xue Q, Ying J, Wang S, Tao X, Zhao J, Mao Y, Wang B, Shao K, Lei W, Wang D, Lv F, Zhao L, Zhang F, Zhao Z, Su K, Tan F, Gao Y, Sun N, Wu D, Yu Y, Ling Y, Wang Z, Duan C, Tang W, Zhang L, He S, Wu N, Wang J, He J*. Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC. J Thorac Oncol. 2020 May;15(5):816-826. (IF=15.609, ESI)